Summary

The UAE cancer diagnostics market is expected to grow at a steady rate in the forecast period. The market growth can be attributed to the rising incidences and prevalence of various types of cancer and the advancing healthcare infrastructure in the country. Technological advancements for better imaging of cancerous cells and an increase in government initiatives and other private organizations to spread awareness regarding early diagnosis & prevention of cancer are anticipated to boost the growth of the UAE cancer diagnostics market in the coming years. Additionally, the growing number of diagnostic laboratories in the country and rising emphasis on health & safety regulations are driving the market growth. Collaborative and independent initiatives taken by the government and private organizations to create cancer awareness are contributing to increased health consciousness, which is aiding the growth of the UAE cancer diagnostics market. The introduction of innovative products along with the rising need for early diagnosis is contributing to the rapid growth of the cancer diagnostics market during the forecast period. Moreover, cancer research organizations, both public and private entities, are investing heavily in research projects to launch advanced diagnostic tools in the market, which is supporting the market growth. Surging demand for early diagnosis of cancer, regular checkups, and routine tests to identify symptoms and find early treatments are anticipated to boost the UAE cancer diagnostics market.
The UAE cancer diagnostics market is segmented by product, technology, application, end user, competitional landscape, and regional distribution. Based on product, the market is divided into consumable and instruments. The consumable segment includes antibodies, kits & reagents, probes and others, and the instruments segment includes pathology instruments, imaging instruments, and biopsy instruments. The consumables segment is expected to hold the largest share in the UAE cancer diagnostics market owing to the increase in the adoption of consumables repetitively for cancer diagnostics and the launch of new and advanced kits.
Leading players in the UAE cancer diagnostics market are GE Healthcare FZE, Abbott Laboratories S A, Roche Diagnostics Middle East FZCO, FUJIFILM Middle East FZE, Danaher Middle East LLC, Agilent Technologies UAE, Hologic Inc. UAE, etc.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F–2027F
Objective of the Study:
• To analyze the historical growth in the market size of UAE cancer diagnostics market from 2017 to 2021.
• To estimate and forecast the market size of UAE cancer diagnostics market from 2022E to 2027F and growth rate until 2027F.
• To classify and forecast UAE cancer diagnostics market based on product, technology, application, end user, region, and company.
• To identify dominant region or segment in the UAE cancer diagnostics market.
• To identify drivers and challenges for UAE cancer diagnostics market.
• To examine competitive developments such as expansions, new services, mergers & acquisitions, etc., in UAE cancer diagnostics market.
• To conduct pricing analysis in the UAE cancer diagnostics market.
• To identify and analyze the profile of leading players operating in UAE cancer diagnostics market.
• To identify key sustainable strategies adopted by market players in UAE cancer diagnostics market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across UAE. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers, which could not be identified due to the limitations of secondary research. TechSci Research analyzed service providers and presence of all major players across the UAE.
TechSci Research calculated the market size of UAE cancer diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Cancer diagnostic service providers and associated equipment manufacturers
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to cancer diagnostics
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service provider, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, UAE cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• UAE Cancer Diagnostics Market, By Product:
o Consumable
 Antibodies
 Kits & Reagents
 Probes
 Others
o Instruments
 Pathology Instruments
 Imaging Instruments
 Biopsy Instruments
• UAE Cancer Diagnostics Market, By Technology:
o IVD Testing
o Imaging
o Biopsy
• UAE Cancer Diagnostics Market, By Application:
o Breast Cancer
o Lung Cancer
o Colorectal Cancer
o Others
• UAE Cancer Diagnostics Market, By End User:
o Hospitals & Clinics
o Diagnostic Laboratories
o Others
• UAE Cancer Diagnostics Market, By Region:
o Abu Dhabi
o Sharjah
o Dubai
o Rest of UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in UAE cancer diagnostics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents